New Zealand based EBOS Group (ASX:EBO) stocks have experienced a significant surge, increasing as much as 9% to NZ$37.120.

This is the highest recorded level since August the previous year.

The last recorded increase was about 6.4%, marking it as the best performing day since November 2022.

The well-known healthcare provider reported an impressive 23% increase in FY underlying NPAT.

The EBOS Group (ASX:EBO) has remained optimistic about the future, stating that July trading conditions were positive.

They expect that such a trend will bring profitable growth in FY24.

Despite this upbeat outlook, the stock has experienced a downfall of 22.4% this year, as of its most recent closing.

EBOS Group (ASX:EBO) is a renowned healthcare provider based in New Zealand.